We found that low ING4 expression correlated with high levels of phosphorylated p65/RelA (p-p65/RelA), an activated form of NF-κB, in breast tumors, suggesting that down-regulation of ING4 may foster NF-κB activation in breast cancer. The gene discussed is ING4; the disease is breast carcinoma.